Home Stem Cell CHA Stem Cell Institute
 
CHA Stem Cell Institute
Overview
Core Technlogy
Facilities
Our People
Global Networks
Recent Achievements
Stem Cell Technology
 
 

CHA Stem Cell Institute (Korea)

CHA Stem Cell Institute (CSCI) is focused on the development of autologous stem
celltechnology.

CSCI's ongoing research involves the production of clinical-grade hES cell lines, purifying stem
cells from cord blood and bone marrow for clinical trial applications.

CSCI's dedicated research facility includes a pharmaceutical-grade GMP facility, two class 5000 clean rooms and our stem cell banks.
Research Laboratories:
  • ES Cell Production
  • Cord Blood Stem Cell Production
  • Placenta & Fetal Stem Cell Production
  • Stem Cell Expansion Research
  • Pancreatic Islet Transplantation
  • Genetically Modified Stem Cell Production
  • Cardiovascular Regeneration
  • Muscular & Bone Regeneration
  • Spinal Cord Injury Regeneration
  • Diabetes Disease Regeneration
  • Brain Disease Regeneration
  • Cancer Stem Cell Research
  • Mesenchymal Stem Cell &Transdifferentiation Research
  • Bioartificial Organ Development
  • Stem Cell Genomics Research
  • Stem Cell Proteomics Research
  • Stem Cell Epigenetics Research
  • Cardiac Muscle Regeneration
  • Germline Stem Cell Production
  • Stress Urinary Incontinence Therapy
  • Hematopoietic Disease Therapy
  • Lmmunity Control Research
  • Dendritic Cell Research
  • Uterine Endometrial Stem Cell Research
  • Osteonecrotic Femoral Head Disease Therapy
  • Stem Cell Production & Genomics Research
    •